Whole blood interferon-γ assay for tuberculosis in children in Japan

Background:  Whole blood interferon‐γ assay QuantiFERON‐TB2G (QFT‐2G), which is a new specific method for diagnosing tuberculosis (TB), has been developed and used in the clinical field. The aim of the present study was to assess the usefulness of QFT‐2G as an indicator, both for diagnosing childhoo...

Full description

Saved in:
Bibliographic Details
Published inPediatrics international Vol. 51; no. 1; pp. 97 - 102
Main Authors Higuchi, Rumiko, Mori, Masaaki, Ozawa, Remi, Miyamae, Takako, Imagawa, Tomoyuki, Nishimaki, Shigeru, Mitsuda, Toshihiro, Aihara, Yukoh, Yokota, Shumpei
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.02.2009
Subjects
Online AccessGet full text
ISSN1328-8067
1442-200X
1442-200X
DOI10.1111/j.1442-200X.2008.02681.x

Cover

More Information
Summary:Background:  Whole blood interferon‐γ assay QuantiFERON‐TB2G (QFT‐2G), which is a new specific method for diagnosing tuberculosis (TB), has been developed and used in the clinical field. The aim of the present study was to assess the usefulness of QFT‐2G as an indicator, both for diagnosing childhood TB and for assessing therapeutic effectiveness. Methods:  The subjects were 61 children introduced to the TB outpatient department for the first time between June 2004 and March 2006. QFT‐2G, the tuberculin test and chest computed tomography (CT) were performed for all patients. Results:  Ten patients having typical characteristics of primary tuberculosis (PTB) on chest CT, and diagnosed as having tubercle bacillus infections, all had positive reaction on QFT‐2G. Of seven patients who had no abnormalities on diagnostic imaging but who reacted positively on QFT‐2G, one developed TB later, and no TB was detected over the period of observation in 44 patients with negative QFT‐2G at their first consultation. Moreover, four patients with non‐tuberculous acid‐fast bacilli in which Mycobacterium avium or Mycobacterium gordonae was detected had negative reaction on QFT‐2G. In addition, all 10 patients with positive reactions on QFT‐2G in whom the subsequent course of the disease was observed had decrease on QFT after treatment. Conclusions:  QFT‐2G is a powerful tool with a wide application both in diagnosis and in assessment of treatment effectiveness in PTB.
Bibliography:ArticleID:PED2681
istex:DEDE54044DB8C91CD346CE19FE453E361BC32F0A
ark:/67375/WNG-QPCBNSTD-X
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1328-8067
1442-200X
1442-200X
DOI:10.1111/j.1442-200X.2008.02681.x